Skip to content
OVistoaIntelligence index
AboutMethodologyPricingDocs
Sign inSign up
BREAKINGPerson found dead in car after it plows into health club in Portland, Oregon13 min ago
Top StoriesUnited StatesCanadaWorldPoliticsGeneralBusinessTechHealthAviationSportsArtificial IntelligencePublishers

US appeals court blocks mail-order access to abortion drugs

11 articles · 10 outlets · spread 1.00

US appeals court blocks mail-order access to abortion drugs
politics9 hr ago

US appeals court blocks mail-order access to abortion drugs

Full coverage view across outlets, lean, source quality, and framing. Compare framing without algorithmic ranking.

11 articles10 outletsSpread 1.0012 claims
OVistoa

Article-level news analysis, transparent scoring, and API tools for readers, publishers, and teams that need source context.

DMCA and copyright review

Copyright owners can submit notices, counter-notices, and source material concerns through the dedicated review flow.

Open DMCA review

Product

  • Home
  • Feed
  • Search
  • Topics
  • Saved

Platform

  • About
  • Methodology
  • Home
  • Search
  • Saved
  • Me

From the Left

1 outlet
  • PBS NewsHour·May 2

    What to know about a mifepristone maker asking the Supreme Court to restore access to the pill by mail

    A maker of the widely used abortion pill mifepristone asked the Supreme Court on Saturday to block an appellate court ruling that cut off mail-order access to the drug just a day earlier, in what was the biggest jolt to abortion policy in the U.S. since the overturning of Roe v. Wade. Danco Laboratories, which is also a defendant in the lawsuit in question, asked to block the New Orleans-based 5th U.S. Circuit Court of Appeals decision while appeals are pending, saying the appellate ruling "injects immediate confusion and upheaval into highly time-sensitive medical decisions." READ MORE: Court restricts abortion access across U.S. by blocking the mailing of mifepristone The appeals court's unanimous ruling Friday marked a substantial victory for abortion opponents seeking to stem the flow of abortion pills prescribed online, which they view as subverting state bans. It requires that mifepristone be distributed only in person and at clinics, overruling regulations set by the federal Food and Drug Administration. "We're now going to see, I think in a way we haven't before, what the nation will look like when abortion bans are actually in effect," said Mary Ziegler, an expert on abortion law and a professor at University

From the Center

10 outlets
  • STAT·May 2

    Federal appeals court blocks mailing of abortion pill mifepristone

    A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone prescriptions. Friday’s unanimous ruling from a three-judge panel of the New Orleans-based 5th U.S. Circuit Court of Appeals is requiring that the abortion pill be distributed only in person and at clinics, overruling regulations set by the federal Food and Drug Administration. The ruling, which is likely to be appealed to the U.S. Supreme Court, is the biggest jolt to abortion policy in the U.S. since the 2022 Supreme Court ruling that overturned Roe v. Wade and allowed states to enforce abortion bans. In the ruling, Judge Kyle Duncan, who was appointed by President Donald Trump, agreed with the state of Louisiana’s contention that allowing the drug to be mailed there makes moot the state’s ban on abortion at all stages of pregnancy. “Every abortion facilitated by FDA’s action cancels Louisiana’s ban on medical abortions and undermines its policy that ‘every unborn child is human being from the moment of conception and is, therefore, a legal person,’” the ruling states. Mifepristone is involved in most abortions in the U.S. Mifepristone was approved in 2000 as

  • MedPage Today·May 2

    Court Restricts Abortion Access Across U.S. by Blocking the Mailing of Mifepristone

    A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking mailing of mifepristone prescriptions. The unanimous ruling Friday from a three-judge panel of the New Orleans-based 5th U.S. Circuit Court of Appeals requires that the abortion pill be distributed only in person and at clinics, overruling regulations set by the FDA. The ruling, which is likely to be appealed to the U.S. Supreme Court, is the biggest jolt to abortion policy in the U.S. since the 2022 Supreme Court ruling that overturned Roe v. Wade and allowed states to enforce abortion bans. In the ruling, Judge Kyle Duncan, who was appointed by President Donald Trump, agreed with the state of Louisiana's contention that allowing the drug to be mailed there makes moot the state's ban on abortion at all stages of pregnancy. "Every abortion facilitated by FDA's action cancels Louisiana's ban on medical abortions and undermines its policy that 'every unborn child is human being from the moment of conception and is, therefore, a legal person,'" the ruling states. Mifepristone is involved in most abortions in the U.S. It was approved in 2000 as a safe and effective way

+4 more

From the Right

0 outlets

No coverage from this perspective yet.

Claim synthesis

Pro users see canonical claims across the cluster and which outlets reported each one.

Learn more

Outlets covering this story

PBS NewsHourFortuneSTATThe GuardianMedPage TodayThe Daily WireCBS NewsNBC NewsUSA TodayGlobal News

First seen

May 1, 2026

Latest

May 2, 2026

Outlets

10

Diversity

91/100

  • Pricing
  • API docs
  • Publishers

    • Account

    • Sign in
    • Create account
    • Reader settings
    • API console

    Legal

    • Terms
    • Privacy
    • Security
    • DMCA

    © 2026 Vistoa. All rights reserved.

    Limited excerpts, attribution, analysis, and outbound publisher links remain core product boundaries.

  • Fortune·May 2

    Federal appeals court blocks mifepristone distribution by mail in biggest jolt to abortion policy since the overturning of Roe v. Wade | Fortune

    In the biggest jolt to abortion policy in the U.S. since the overturning of Roe v. Wade, a federal appeals court has restricted access to one of the most common ways to end early pregnancies, by blocking the mailing of mifepristone prescriptions. The unanimous ruling Friday from the New Orleans-based 5th U.S. Circuit Court of Appeals marks a substantial victory for abortion opponents seeking to stem the flow of abortion pills prescribed online that they view as subverting state bans on the procedure. The ruling, which is expected to be appealed to the U.S. Supreme Court, requires that mifepristone be distributed only in person and at clinics, overruling regulations set by the federal Food and Drug Administration. Here’s what to know. Impact extends beyond states with abortion bans Frustrated with a lack of federal action against medicated abortions, Louisiana Attorney General Liz Murrill sued the FDA last month, saying its regulations undermined the state’s ban on abortions at all stages of pregnancy. “The regulation creates an effective way for an out-of-state prescriber to place the drug in the hands of Louisianans in defiance of Louisiana law,” Judge Kyle Duncan, who was appointed by President Donald Trump, wrote in the ruling.

  • The Guardian·May 2

    US appeals court blocks mail-order access to abortion drugs

    Access to mifepristone, the FDA-approved medication used to end pregnancy, could become severely limited following a ruling from US appeals court on Friday, which temporarily blocked the drug from being dispensed through the mail.The decision is for now the most sweeping threat to abortion access since the supreme court rolled back abortion rights in 2022, said Kelly Baden, vice-president at the Guttmacher Institute, an abortion rights advocacy group.“If allowed to stand, it would severely restrict access to mifepristone in every state, including those where abortion is broadly legal and where voters have acted to protect abortion rights,” she said.The so-called “abortion pill” is part of a two-drug regimen backed by decades of evidence for its efficacy and safety, and is used in the majority of abortions in the US.Usage has risen in recent years, especially in the aftermath of the 2022 ruling from the supreme court that overturned federal protections for a right to an abortion. In the year after that decision, the FDA formally modified its regulations to allow the drug to be prescribed online, expanding its use even in states where abortion care was being constricted.The drug has become a key target for the anti-abortion movement, and a

  • The Daily Wire·May 1

    Court Issues Major Ruling On Biden Abortion Pill Policy

    In a major legal victory for the pro-life movement, the U.S. Court of Appeals for the Fifth Circuit on Friday ordered a nationwide halt to a Biden-era policy allowing the abortion pill mifepristone to be prescribed online and delivered by mail, ruling that the regulation is likely unlawful and poses ongoing harm while litigation proceeds.The unanimous panel granted Louisiana’s request to block the Food and Drug Administration’s 2023 rules, which removed longstanding in-person requirements for the drug. The court found the state is “strongly likely to succeed on the merits” of its challenge and is suffering irreparable harm from the policy, including violations of its pro-life laws and increased taxpayer-funded medical costs.“The public interest is not served by perpetuating a medical practice whose safety the agency admits was inadequately studied,” the court wrote. “Indeed, the public interest demands the opposite.” The ruling immediately blocks the mail-order distribution framework put in place after the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, when the Biden administration expanded access to chemical abortion nationwide. Under the 2023 rules, mifepristone could be prescribed via telehealth and shipped without an in-person doctor visit.Louisiana challenged the policy under the Administrative Procedure Act, arguing the

  • CBS News·May 1

    Appeals court blocks mailing of abortion pill mifepristone in U.S.

    May 1, 2026 / 7:24 PM EDT / CBS/AP Add CBS News on Google A federal appeals court on Friday restricted access to one of the most common means of abortion in the U.S. by blocking mailing of prescriptions of mifepristone.A panel of the New Orleans-based 5th U.S. Circuit Court of Appeals is requiring that the abortion pill be distributed only in person at clinics."Every abortion facilitated by FDA's action cancels Louisiana's ban on medical abortions and undermines its policy that 'every unborn child is human being from the moment of conception and is, therefore, a legal person,'" the ruling states.In their ruling, the judges stated that the current regulation "creates an effective way for an out-of-state prescriber to place the drug in the hands of Louisianans in defiance of Louisiana law." Judges have long deferred to the Food and Drug Administration's judgments on the safety and appropriate regulation of drugs.FDA officials under President Trump have repeatedly stated the agency is conducting a new review of mifepristone's safety, at the direction of the president.The judges noted in their ruling that the FDA "could not say when that review might be complete and admitted it was still collecting data." In a